These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17635511

  • 1. Bortezomib-associated cutaneous vasculitis.
    Garcia-Navarro X, Puig L, Fernández-Figueras MT, Dalmau J, Roe E, Alomar A.
    Br J Dermatol; 2007 Oct; 157(4):799-801. PubMed ID: 17635511
    [No Abstract] [Full Text] [Related]

  • 2. Images in clinical Medicine. Bortezomib-induced skin lesions.
    Agterof MJ, Biesma DH.
    N Engl J Med; 2005 Jun 16; 352(24):2534. PubMed ID: 15958809
    [No Abstract] [Full Text] [Related]

  • 3. Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?
    Gerecitano J, Goy A, Wright J, MacGregor-Cortelli B, Neylon E, Gonen M, Esseltine D, Boral A, Schenkein D, Busam K, Teruya-Feldstein J, Sachs D, O'Connor OA.
    Br J Haematol; 2006 Aug 16; 134(4):391-8. PubMed ID: 16882131
    [Abstract] [Full Text] [Related]

  • 4. Bortezomib-induced skin eruption.
    Sanchez-Politta S, Favet L, Kerl K, Dietrich PY, Piguet V.
    Dermatology; 2008 Aug 16; 216(2):156-8. PubMed ID: 18216478
    [Abstract] [Full Text] [Related]

  • 5. Persistent supravenous eruption induced by intravenous bortezomib therapy.
    Mataix J, Betlloch I, Palmero F, Romero A.
    Br J Dermatol; 2008 Apr 16; 158(4):863-4. PubMed ID: 18284402
    [No Abstract] [Full Text] [Related]

  • 6. Bortezomib-induced cutaneous lesions in multiple myeloma patients: a case report.
    Rodríguez-Martín M, Sáez-Rodríguez M, García-Bustínduy M, Martín-Herrera A, Noda-Cabrera A.
    Dermatol Online J; 2008 Nov 15; 14(11):14. PubMed ID: 19094852
    [Abstract] [Full Text] [Related]

  • 7. Bortezomib-induced Sweet syndrome.
    Knoops L, Jacquemain A, Tennstedt D, Theate I, Ferrant A, Van den Neste E.
    Br J Haematol; 2005 Oct 15; 131(2):142. PubMed ID: 16197442
    [No Abstract] [Full Text] [Related]

  • 8. Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?
    Pitini V, Arrigo C, Altavilla G, Naro C.
    Leuk Res; 2007 Jul 15; 31(7):1027-8. PubMed ID: 17134751
    [No Abstract] [Full Text] [Related]

  • 9. Cutaneous lymphoid perivascular reaction with atypical CD30+ T cells in a patient with multiple myeloma treated with bortezomib.
    Dehesa L, Bastida J, Limeres-González M, Campos-Adsuar C, Gómez-Duaso J.
    Clin Exp Dermatol; 2009 Dec 15; 34(8):e1031-2. PubMed ID: 20055832
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bortezomib-induced histiocytoid Sweet syndrome.
    Murase JE, Wu JJ, Theate I, Cole GW, Barr RJ, Dyson SW.
    J Am Acad Dermatol; 2009 Mar 15; 60(3):496-7. PubMed ID: 19231647
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma.
    Wu KL, Heule F, Lam K, Sonneveld P.
    J Am Acad Dermatol; 2006 Nov 15; 55(5):897-900. PubMed ID: 17052502
    [Abstract] [Full Text] [Related]

  • 15. Sweet-like lesions induced by bortezomib: a review of the literature and a report of 2 cases.
    Truchuelo M, Bagazgoitia L, Alcántara J, Velasco D, Carrillo R.
    Actas Dermosifiliogr; 2012 Nov 15; 103(9):829-31. PubMed ID: 22652505
    [No Abstract] [Full Text] [Related]

  • 16. Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.
    Fang B, Song Y, Ma J, Zhao RC.
    Acta Haematol; 2007 Nov 15; 118(2):65-7. PubMed ID: 17505132
    [No Abstract] [Full Text] [Related]

  • 17. Cutaneous vasculitis associated with rofecoxib.
    Lillicrap MS, Merry P.
    Rheumatology (Oxford); 2003 Oct 15; 42(10):1267-8. PubMed ID: 14508048
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment.
    Shoda H, Inokuma S, Yajima N, Tanaka Y, Setoguchi K.
    Ann Rheum Dis; 2005 Apr 15; 64(4):651-2. PubMed ID: 15769928
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.